Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India

• Rajesh D. Deshmukh ,

  Contributed equally to this work with: Rajesh D. Deshmukh, D. J. Dhande

  * E-mail: pohivtb.naco@gmail.com

  Current address: Department of AIDS Control (NACO), Ministry of Health and Family Welfare, New Delhi, India

  Affiliation World Health Organisation, Country Office for India, New Delhi, India

  ⨯
• D. J. Dhande ,

  Contributed equally to this work with: Rajesh D. Deshmukh, D. J. Dhande

  Affiliation Department of Pulmonary Medicine, Drug Resistant TB centre, Lata Mangeshkar Hospital, Nagpur, Maharashtra, India

  ⨯
• Kuldeep Singh Sachdeva,

  Affiliation Central TB Division, Ministry of Health and Family Welfare, New Delhi, India

  ⨯
• Achuthan Sreenivas,

  Affiliation World Health Organisation, Country Office for India, New Delhi, India

  ⨯
• A. M. V. Kumar,

  Affiliation International Union against Tuberculosis and Lung Disease, South East Asia Office, New Delhi, India

  ⨯
• Srinath Satyanarayana,

  Affiliation Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada

  ⨯
• Malik Parmar,

  Affiliation World Health Organisation, Country Office for India, New Delhi, India

  ⨯
• Patrick K. Moonan,

  Affiliation Division of TB Elimination, International Research Programs Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georiga, United States of America

  ⨯
• Terrence Q. Lo

  Affiliation Division of TB Elimination, International Research Programs Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georiga, United States of America

  ⨯